PeptideDB

Terephthalic acid-13C2 (Terephthalic acid 13C2) 121191-53-5

Terephthalic acid-13C2 (Terephthalic acid 13C2) 121191-53-5

CAS No.: 121191-53-5

Terephthalic acid-13C2 is a 13C (carbon 13)-labeled Terephthalic acid. Terephthalic acid is an isomer of three phthalate
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Terephthalic acid-13C2 is a 13C (carbon 13)-labeled Terephthalic acid. Terephthalic acid is an isomer of three phthalates and is the precursor of polyester PET, which may be utilized to make clothing and plastics.

Physicochemical Properties


Molecular Formula C613C2H6O4
Molecular Weight 168.12
Exact Mass 168.033
CAS # 121191-53-5
Related CAS # Terephthalic acid;100-21-0
PubChem CID 16213482
Appearance White to off-white solid powder
Density 1.451g/cm3
Melting Point >300ºC(lit.)
Index of Refraction 1.617
LogP 1.083
Hydrogen Bond Donor Count 2
Hydrogen Bond Acceptor Count 4
Rotatable Bond Count 2
Heavy Atom Count 12
Complexity 169
Defined Atom Stereocenter Count 0
SMILES

C1=CC(=CC=C1[13C](=O)O)[13C](=O)O

InChi Key KKEYFWRCBNTPAC-BFGUONQLSA-N
InChi Code

InChI=1S/C8H6O4/c9-7(10)5-1-2-6(4-3-5)8(11)12/h1-4H,(H,9,10)(H,11,12)/i7+1,8+1
Chemical Name

terephthalic acid
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro Drug compounds have included stable heavy isotopes of carbon, hydrogen, and other elements, mostly as quantitative tracers while the drugs were being developed. Because deuteration may have an effect on a drug's pharmacokinetics and metabolic properties, it is a cause for concern [1].
References

[1]. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.

[2]. The induction of bladder stones by terephthalic acid, dimethyl terephthalate, and melamine (2,4,6-triamino-s-triazine) and its relevance to risk assessment. Regul Toxicol Pharmacol. 1985 Sep;5(3):294-313.


Solubility Data


Solubility (In Vitro) DMSO: 125 mg/mL (743.52 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.08 mg/mL (12.37 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 5.9481 mL 29.7407 mL 59.4813 mL
5 mM 1.1896 mL 5.9481 mL 11.8963 mL
10 mM 0.5948 mL 2.9741 mL 5.9481 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.